Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page
- Check4 days agoChange DetectedAdds several historical versions (183–187) to the Record History, including an update to Study Status on 2026-03-12 and earlier dates. These entries broaden the historical record of the study's updates.SummaryDifference0.4%

- Check12 days agoChange DetectedDifference0.5%

- Check19 days agoChange DetectedAdded new entries to the Record History showing a new Document Section and updated Study Status entries. These updates extend the version list up to 2026-02-25.SummaryDifference0.4%

- Check26 days agoChange DetectedNew history entries were added for 2026-02-17 and 2026-02-18, including an updated Study Status (version 171). The 2025-11-26 entry was removed.SummaryDifference0.2%

- Check33 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed in the page history. This is a minor site revision update and does not affect the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page history now includes a new revision entry for v3.4.1 and removes the older v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.